Hershfield JR - Search Results

1

Artificial Blood Development Implications for Military Medicine.

Melanson VR, Hershfield JR, Deegan MK, Cho H, Perinon D, Bateman SL, Barnhill JC. Melanson VR, et al. Among authors: hershfield jr. J Spec Oper Med. 2023 Oct 5;23(3):63-69. doi: 10.55460/OVOP-V2QC. J Spec Oper Med. 2023. PMID: 37253155 Review.

2

A Review of Force Health Protection Aspects of Lyme Disease in the U.S. Military.

Melanson VR, Bateman SL, Hering K, Weiss TJ, Reilly JL, Davis KT, Gramlich VA, Jankovich A, Daffin M, Hershfield JR, Barnhill JC. Melanson VR, et al. Among authors: hershfield jr. Mil Med. 2024 Sep 10:usae415. doi: 10.1093/milmed/usae415. Online ahead of print. Mil Med. 2024. PMID: 39255240

3

In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis.

Steenbergen J, Tanaka SK, Miller LL, Halasohoris SA, Hershfield JR. Steenbergen J, et al. Among authors: hershfield jr. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02434-16. doi: 10.1128/AAC.02434-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28223382 Free PMC article.

4

Plantazolicin is an ultra-narrow spectrum antibiotic that targets the Bacillus anthracis membrane.

Molohon KJ, Saint-Vincent PMB, Park S, Doroghazi JR, Maxson T, Hershfield JR, Flatt KM, Schroeder NE, Ha T, Mitchell DA. Molohon KJ, et al. Among authors: hershfield jr. ACS Infect Dis. 2016 Mar 10;2(3):207-220. doi: 10.1021/acsinfecdis.5b00115. Epub 2015 Dec 23. ACS Infect Dis. 2016. PMID: 27152321 Free PMC article.

5

Membrane-Targeting DCAP Analogues with Broad-Spectrum Antibiotic Activity against Pathogenic Bacteria.

Hurley KA, Heinrich VA, Hershfield JR, Demons ST, Weibel DB. Hurley KA, et al. Among authors: hershfield jr. ACS Med Chem Lett. 2015 Mar 1;6(4):466-71. doi: 10.1021/acsmedchemlett.5b00024. eCollection 2015 Apr 9. ACS Med Chem Lett. 2015. PMID: 25941556 Free PMC article.

6

Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidase.

Steed DB, Liu J, Wasbrough E, Miller L, Halasohoris S, Miller J, Somerville B, Hershfield JR, Romesberg FE. Steed DB, et al. Among authors: hershfield jr. Antimicrob Agents Chemother. 2015 Jul;59(7):3887-98. doi: 10.1128/AAC.00181-15. Epub 2015 Apr 20. Antimicrob Agents Chemother. 2015. PMID: 25896690 Free PMC article.

7

3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screening.

Hu X, Compton JR, Abdulhameed MD, Marchand CL, Robertson KL, Leary DH, Jadhav A, Hershfield JR, Wallqvist A, Friedlander AM, Legler PM. Hu X, et al. Among authors: hershfield jr. J Med Chem. 2013 Jul 11;56(13):5275-87. doi: 10.1021/jm4001242. Epub 2013 Jul 1. J Med Chem. 2013. PMID: 23815100

8

Mutational analysis of aspartoacylase: implications for Canavan disease.

Hershfield JR, Pattabiraman N, Madhavarao CN, Namboodiri MA. Hershfield JR, et al. Brain Res. 2007 May 7;1148:1-14. doi: 10.1016/j.brainres.2007.02.069. Epub 2007 Mar 3. Brain Res. 2007. PMID: 17391648 Free PMC article.

9

Aspartoacylase is a regulated nuclear-cytoplasmic enzyme.

Hershfield JR, Madhavarao CN, Moffett JR, Benjamins JA, Garbern JY, Namboodiri A. Hershfield JR, et al. FASEB J. 2006 Oct;20(12):2139-41. doi: 10.1096/fj.05-5358fje. Epub 2006 Aug 25. FASEB J. 2006. PMID: 16935940

10

SH-SY5Y neuroblastoma cells: a model system for studying biosynthesis of NAAG.

Arun P, Madhavarao CN, Hershfield JR, Moffett JR, Namboodiri MA. Arun P, et al. Among authors: hershfield jr. Neuroreport. 2004 May 19;15(7):1167-70. doi: 10.1097/00001756-200405190-00017. Neuroreport. 2004. PMID: 15129167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters